Endogenous Myc maintains the tumor microenvironment
- 8 April 2011
- journal article
- research article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 25 (9), 907-916
- https://doi.org/10.1101/gad.2038411
Abstract
The ubiquitous deregulation of Myc in human cancers makes it an intriguing therapeutic target, a notion supported by recent studies in Ras-driven lung tumors showing that inhibiting endogenous Myc triggers ubiquitous tumor regression. However, neither the therapeutic mechanism nor the applicability of Myc inhibition to other tumor types driven by other oncogenic mechanisms is established. Here, we show that inhibition of endogenous Myc also triggers ubiquitous regression of tumors in a simian virus 40 (SV40)-driven pancreatic islet tumor model. Such regression is presaged by collapse of the tumor microenvironment and involution of tumor vasculature. Hence, in addition to its diverse intracellular roles, endogenous Myc serves an essential and nonredundant role in coupling diverse intracellular oncogenic pathways to the tumor microenvironment, further bolstering its credentials as a pharmacological target.Keywords
This publication has 32 references indexed in Scilit:
- Reflecting on 25 years with MYCNature Reviews Cancer, 2008
- Modes of resistance to anti-angiogenic therapyNature Reviews Cancer, 2008
- Simian virus 40 large T overcomes p300 repression of c-MycVirology, 2008
- Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progressionProceedings of the National Academy of Sciences of the United States of America, 2008
- SV40 small T antigen and PP2A phosphatase in cell transformationCancer and Metastasis Reviews, 2008
- The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1βGenes & Development, 2006
- Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesisProceedings of the National Academy of Sciences of the United States of America, 2006
- Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumorsCancer Cell, 2005
- Reversible Activation of c-Myc in SkinMolecular Cell, 1999
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989